A Case Report of Silver-Russell Syndrome in Iran by Mahdian, Arezoo et al.
                                               Case Report 
                ISSN 2645-4351 
 
Copyright© 2018, Author(s). This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License  
 
A Case Report of Silver-Russell Syndrome in Iran 
Arezoo Mahdian a, Shiva Safari b, Nazanin Sanagoo b 
 
1. aAssistant Professor, Orthodontics Research Center, School of Dentistry, Shiraz University of Medical Sciences, Shiraz, Iran. 
2. bPostgraduate Student, Dept. of Orthodontics, School of Dentistry, Shahid Beheshti University of Medical Sciences. Tehran, Iran. 
3. Correspondence to Arezoo Mahdian (email: dr.arezoomahdian@gmail.com). 
(Submitted: 20 January 2020 – Revised version received: 12 May 2020 – Accepted: 20 May 2020– Published online: Summer 2020) 
Objectives Silver-Russell syndrome (SRS) is a rare genetic disorder which is typically characterized by prenatal and 
postnatal growth failure and asymmetry in the size of the two halves or other parts of the body. Herein, we report 
accurate diagnosis and management of a patient with SRS. 
Case Our patient was a 9-year-old boy with short stature and dysmorphic facial profile. The patient was diagnosed with 
SRS based on clinical and radiographic features such as short stature, triangular face, mandibular hypoplasia and 
clinodactyly. He was under growth hormone therapy since birth. The orthodontic treatment plan was space 
management for permanent teeth and growth modification to accelerate mandibular growth potential.  
Conclusion Early diagnosis and treatment are very important for SRS patients. Growth hormone therapy is often 
prescribed. It is necessary to persuade these patients to undergo early orthodontic intervention and comply with the 
follow-up protocol. 
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Introduction 
Silver-Russell syndrome (SRS) which is also named as 
asymmetry dwarf-dysgenesis syndrome
1
, is defined as ―a 
distinct syndromic growth disorder in which prenatal and 
postnatal growth failure are concomitant with other 
characteristic features, including relative macrocephaly at 
birth, protruding forehead in the early life, body asymmetry 
and considerable feeding difficulties‖.
2 
Silver and Russell were the first to describe a syndrome of 
intrauterine dwarfism distinguishable at birth. Silver et al. 
(1953)
3
 described two children with congenital hemi-
hypertrophy, low birth weight, short stature and increased 
urinary gonadotropins. Russell (1954)
4
, however, reported 
five children with intrauterine growth retardation and 
anomalies of the skull and face. Even as both the authors 
thought they were describing two different conditions, the 
two phenotypes were later recognized as a single entity and 
the disease was thus categorized as SRS, using both their 
names. The occurrence of SRS ranges from 1 in 3000 to 1 
in 100,000 live births.
5
 The disease equally affects all 
races
6-8
 and both sexes.
9
 This syndrome is almost rare and a 
few cases have been reported in the recent years (Table 1). 
Table 1- Recent case reports of Silver-Russell syndrome 
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Russell-Silver syndrome with cleft 
palate: a case report 
2018 Japan 
 
At present, the two genotypic anomalies clearly 
recognizable in the initial stage of the disease include loss 
of methylation on chromosome 11p15, imprinting the 
center region 1
15
 and the maternal uni-parental 
chromosome 7 dismay (upd (7) mat)
16
. 
An intrauterine challenge or stress at six or seven weeks of 
gestation is the Russell’s hypothesis; whereas, another 
hypothesis reported either an end-organ unresponsiveness 
to growth hormone or biostructural abnormality in growth 
hormone molecule to be responsible. However, none of 
these theories have been confirmed. The etiology has yet 
to be entirely elucidated
17
. Almost all children with SRS 
are born small for gestational age and postnatal catch up 
growth is rare in most of them
2
. 
 The characteristic features described were triangular 
shaped face with a broad forehead, pointed small chin and 
a wide thin 'shark-like' mouth. Although each author 
emphasized rather different features, the composite 
features have been identified as the Russell-Silver 
syndrome, and efforts to separate the Silver syndrome 
from the Russell syndrome, depending on whether 




Clinically obvious limb asymmetry occurs in about 60% 
of reported patients. The musculoskeletal manifestations 
of SRS were studied in 25 cases. The most common 
manifestations were short stature (25 cases), limb-length 
discrepancy (23 cases), clinodactyly (19 cases), 
metacarpal bone and phalangeal abnormalities (13 cases), 
scoliosis (9 cases), foot syndactylism (5 cases), and 
developmental dysplasia of the hips (3 cases)
19
. 
Because the symptoms of SRS are primarily due to the 
lack of growth hormone, early diagnosis and treatment of 
this syndrome is very important to prevent joint 
deformities and other growth problems. A case of SRS is 
reported for better understanding of the problem and to 
evade wrong diagnosis and management. 
Case Report 
Silver-Russell Syndrome in Iran                            Arezoo Mahdian, et al.                                                                    
 
Journal Dental School; Vol 37, No.3, Summer 2020; 103-107  104  
Case 
A 9-year-old boy with a chief complaint of crowding in his 
upper and lower dental arch presented to the Orthodontics 
Department, Shahid Beheshti University of Medical 
Sciences. He had non-consanguineous parents and his 
mother reported no complication during pregnancy. He had 
a younger sister who was born normally. His mother had a 
history of gestational diabetes, but no medication was 
prescribed. He was delivered via a Caesarean section at 36 
weeks of gestation. At birth, he weighed 1800 g and was 40 
cm tall, with the head circumference of 34 cm. His 
developmental milestones were somewhat delayed (sitting 
at 1 year and walking at 2 years). Other family members 
had no history of such type of illness. On physical 
examination, the boy was alert and cooperative. His weight 
was 11 kg, his head circumference was 51 cm and his 
height was 105 cm which was short for his age. His BMI of 
9.07 kg/m² indicated that he was under weight. He had a 
poor appetite since childhood. Intelligence and 
psychomotor development were normal. He had normal 
speech. He was under speech therapy and physiotherapy 
from the age of 2. 
His skull and face examination revealed triangular face with 
relative macrocephaly, low-set prominent ears (Figure 1) 
and mandibular hypoplasia and micrognathia in the profile 
view (Figure 2). 
 
Figure 1-Triangular face    
 
Figure 2- Mandibular hypoplasia 
Posterior-anterior cephalometry revealed asymmetric 
inferior border of the mandible and mild chin deviation to 
the right side. Mandibular hypoplasia and high mandibular 
plane angle were obvious on the lateral cephalogram 
(Figure 3). 
The hands showed bilateral clinodactyly of the fifth finger. 
The toes were normal (Figure 4). His right hand was 
slightly taller than the left one but the length of his legs 
was equal (Figure 5). Both his feet were flat. 
 
Figure 3- Lateral cephalogram 
 
Figure 4- Clinodactyly of the fifth finger 
 
 
Figure 5- Short stature and asymmetry in length of 
upper extremities 
He had hypospadias, which is a common congenital 
disease of the penis with an abnormal ventral opening of 
the meatus of the urethra. Six operations had been 
performed to treat this condition. 
Head magnetic resonance imaging and 
electroencephalography disclosed normal results. Routine 
investigations including blood count and urine were 
normal. No cytogenetic or molecular investigations were 
performed. 
He had a history of 26 hospitalizations for a variety of 
reasons such as pancreatitis, pneumonia, malnutrition, 
asthma, hypospadias, tooth restoration, etc. 
Intraoral examination revealed a highly arched palate, 
restored teeth, micrognathia with severe space deficiency 
for eruption of permanent teeth, and posterior cross bite 
(Figure 6). There was no hypodontia or microdontia. 
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Figure 6- Severe space deficiency for eruption of 
permanent teeth 
He was under growth hormone therapy since birth. At the 
time of visit, the medications had been discontinued. 
The Netchine-Harbison clinical scoring system (NH-CSS) 
is the only diagnostic scoring system for SRS which is 
shown in Table 2.  
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eding tube or  cyproheptadine for appetite 
stimulation 
* Schedule for Deficit Syndrome 
** Leg length discrepancy 
To ensure clinical diagnosis when all molecular testingare 
normal, it has been recommended that only patients that 
score at least four of the six criteria, including both 
prominent forehead and relative macrocephaly, should be 
diagnosed with ―clinical SRS‖. 
Diagnosis of SRS in our patient was madebased on the 
clinical and radiographic features by the attending 
pediatrician at birth. No genetic testing was performed for 
the patient due to thelack of ethical and rational 
justification. 
Discussion 
Definition and etiology 
SRS is a clinically and genetically heterogeneous disorder 
of growth with a spectrum of further dysmorphic features. 
It has been reported that 7% to 10% of patients with this 
syndrome have a defect in a gene called the maternal uni-
parental disomy on chromosome 7. Most cases occur in 
children whose parents have no history of the disease.
5
 It 
is essential to note that no single description to date can 
account for the heterogeneity of the phenotypic findings. 
 
Features, diagnosis, and differential diagnosis 
Outcomes that have been reported in over 50% of all 
patients with SRS are short stature, craniofacial 
disproportion, low birth weight, asymmetry, normal 
intelligence, downward curvature of the mouth (shark 
mouth) and clinodactyly of the fifth finger. The described 
patient in this report also had a short stature, clinodactyly, 
triangular face, and normal intelligence. 
Normal intelligence is the rule in this syndrome. However, 
there may be some delay in the early motor milestones due 
to decreased muscle bulk and relatively large head.
5
 
Major maxillofacial features that have been described are 
a highly arched palate, delayed tooth eruption, 
microdontia, hypodontia, absence of secondary teeth, 
blunted condyles, and crowding.
20
 Crowding might be 
severe in the lower arch, with displacement of lower 
incisors into a lingual position. Micrognathia is common, 
with lack of mandibular growth, which results in a small, 
pointed chin and an overbite. Velopharyngeal 
insufficiency with or without a submucosal cleft is 
common in patients with 11p15 LOM SRS. Otitis media is 
common in young children with SRS7 and seems to be 
improved by orthodontic treatment.
21
 
Diagnosis of SRS remains clinical as no certain etiology 
or specific tests have been established. The five core 
clinical diagnostic criteria include: 
1. Intrauterine retardation 
2. Poor postnatal growth 
3. Preservation of occipitofrontal circumference 
4. Typical facial phenotype 
5. Asymmetry specially in the extremities 
Patients whose features fulfill the four of these five criteria 
could be diagnosed with SRS.
6, 22
 The patient presented in 
this paper fulfilled all of the above-mentioned criteria. 
The differential diagnosis of SRS includes other 
syndromes of primordial dwarfism with characteristic 
facial features such as Bloom syndrome, 3M with 
intrauterine growth retardation, Nijmegen breakage 
syndrome, Meier-Gorlin syndrome, Mulibreynanism, 
SHORT syndrome, fetal alcohol syndrome, floating 
harbour syndrome, IMAGe syndrome and other 
chromosomal, endocrine, and metabolic disturbances that 
would account for the short stature.
23, 24
 To differentiate 
SRS from the other syndromes and conditions, the specific 
features of SRS should be considered. These include 
relative microcephaly (Table 1), prominent developmental 
delay or intellectual disability, absence of severe feeding 
difficulties and/or the presence of additional congenital 
anomalies, facial dysmorphism or other atypical features 
of SRS. The head circumference of our patient was 51 cm 
which is considered as macrocephaly in comparison with 
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its normal size. This property rules out syndromes 
described in Table 3.The lack of intense mental disability 
makes this syndrome different from many other conditions 
such as fetal alcohol syndrome. 





Fetal alcohol syndrome 
Nijmegen breakage syndrome 
IGF1 mutation 
IGF1R mutation or deletion 
Meier-Gorlin syndrome 
     *Microcephalicosteodysplastic primordial dwarfism type II 
A precise diagnosis is extremely important for 
management. Response to growth hormone treatment, if 
given, differs depending on the underlying syndromic 
diagnosis.
2
 Growth hormone treatment is contraindicated 
in patients with chromosome breakage disorders, such as 





Management and prognosis 
The management of SRS is conservative, comprising of 
growth hormone therapy, high calorie diet, limb 
lengthening/shoe lift in more severe cases,
26
 nutritional 
support and physical therapy to alleviate the skeletal 
symptoms. The use of growth hormone was approved by 
the US Food and Drug Administration in 2001 in children 
born small for their gestational age who have not yet 
manifested sufficient catch-up growth at the age of 2 
years; however, growth hormone therapy was started in 
our patient from birth and stopped at the age of five. 
Recombinant human growth hormone is given daily via 
subcutaneous injection at a dose of 0.48 mg/kg per 
week.
27, 28
Stanhope et al. (1998) showed that growth 
hormone therapy caused short term growth acceleration in 




After treatment, the body height may increase noticeably 
in the first year, but decrease progressively over the years. 
Bone age tends to mature fast, and no finding is available 
on the effect of recombinant human growth hormone 
treatment on the final height of SRS patients.
29
 
SRS has a comparatively good prognosis. In the absence 
of growth hormone therapy, the final adult height reaches 
142.5 to 145 cm in males and 146.5 cm in females.
21
 
Johnson and Mokuolu reported cases of ―sudden‖ infant 




The oropharyngeal function and facial appearance can be 
improved by orthodontic intervention in children with 
SRS. Multiple orthodontic techniques such as distraction 
osteogenesis have been used successfully.
24
 Currently, the 
most effective technique to change the V-shape maxillary 
arch is rapid palatal expansion.
30
 It is recommended to 
develop a referral relationship with a maxillofacial team or 
an orthodontist experienced in caring for such patients.  
Precise history, and clinical and radiographic examination 
can be sufficient for proper diagnosis. 
The orthodontic treatment plan in our patient was space 
management by extraction of some deciduous teeth, arch 
expansion and space retaining for eruption of permanent 
teeth. Growth modification is considered as the next step 
for the patient. 
Conclusion 
The necessity of early diagnosis and timely treatment is 
based on the SRS etiology. Since the growth hormone 
deficiency is the primary reason for joint deformities and 
other growth problems, it is essential that the syndrome is 
diagnosed as soon as possible and appropriate treatment is 
started. It is recommended to develop a referral 
relationship with a maxillofacial team or an orthodontist 
experienced in caring for such patients. Precise history, 
and clinical and radiographic examination can be 
sufficient for proper diagnosis. 
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